BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23378360)

  • 1. An unusual cause of oesophageal variceal bleeding in a Chinese human immunodeficiency virus-infected patient.
    Hui YT; Lam WY; Lee MP; Lam TW; Li P
    Hong Kong Med J; 2013 Feb; 19(1):77-9. PubMed ID: 23378360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-cirrhotic portal hypertension associated with didanosine: An unusual cause of gastrointestinal bleeding].
    Gómez-Rubio J; Bárcena-Atalaya AB; Macías-García L; Lozano de León-Naranjo F
    Med Clin (Barc); 2015 Jul; 145(1):45. PubMed ID: 25510631
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-cirrhotic portal hypertension due to didanosina. A rare case].
    Gamero MT; Gallardo MS; Aguilar V; Bravo E; Guevara J; Mejia F
    Rev Gastroenterol Peru; 2017; 37(1):87-90. PubMed ID: 28489843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
    Vispo E; Maida I; Barreiro P; Moreno V; Soriano V
    HIV Clin Trials; 2008; 9(6):440-4. PubMed ID: 19203910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
    Kovari H; Ledergerber B; Peter U; Flepp M; Jost J; Schmid P; Calmy A; Mueller NJ; Muellhaupt B; Weber R;
    Clin Infect Dis; 2009 Aug; 49(4):626-35. PubMed ID: 19589079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cirrhotic portal hypertension in HIV-infected individuals.
    Scourfield A; Waters L; Holmes P; Panos G; Randell P; Jackson A; Mandalia S; Gazzard B; Nelson M
    Int J STD AIDS; 2011 Jun; 22(6):324-8. PubMed ID: 21680667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection.
    Yajima K; Uehira T; Otera H; Koizumi Y; Watanabe D; Kodama Y; Kuzushita N; Nishida Y; Mita E; Mano M; Shirasaka T
    J Infect Chemother; 2014 Sep; 20(9):582-5. PubMed ID: 25034388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding].
    Schouten JN; Verheij J; Janssen HL
    Ned Tijdschr Geneeskd; 2010; 154():A1276. PubMed ID: 20456763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
    Mendizabal M; Craviotto S; Chen T; Silva MO; Reddy KR
    Ann Hepatol; 2009; 8(4):390-5. PubMed ID: 20009143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular regenerative hyperplasia of the liver associated with didanosine persists for years even after its interruption.
    Hofmaenner D; Kovari H; Weber A; Weishaupt D; Speck RF
    BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.
    Schiano TD; Uriel A; Dieterich DT; Fiel MI
    Virchows Arch; 2011 Feb; 458(2):231-5. PubMed ID: 21057809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of upper gastrointestinal endoscopy in evaluation of portal hypertension].
    Melinte-Popescu M; Bălan G
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1003-6. PubMed ID: 22276436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
    Chang PE; Miquel R; Blanco JL; Laguno M; Bruguera M; Abraldes JG; Bosch J; Garcia-Pagan JC
    Am J Gastroenterol; 2009 Jul; 104(7):1707-14. PubMed ID: 19471257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-cirrhotic portal hypertension in HIV mono-infected patients.
    Jackson BD; Doyle JS; Hoy JF; Roberts SK; Colman J; Hellard ME; Sasadeusz JJ; Iser DM
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1512-9. PubMed ID: 22497527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.
    Schouten JN; Van der Ende ME; Koëter T; Rossing HH; Komuta M; Verheij J; van der Valk M; Hansen BE; Janssen HL
    Aliment Pharmacol Ther; 2012 Nov; 36(9):875-85. PubMed ID: 22971050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal hypertension and variceal hemorrhage.
    Sass DA; Chopra KB
    Med Clin North Am; 2009 Jul; 93(4):837-53, vii-viii. PubMed ID: 19577117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.
    Saifee S; Joelson D; Braude J; Shrestha R; Johnson M; Sellers M; Galambos MR; Rubin RA
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1167-9. PubMed ID: 18639498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding.
    Dell'era A; Bosch J
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():8-15; discussion 16-7. PubMed ID: 15335392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endoscopy in primary prophylaxis for esophageal variceal bleeding.
    Albillos A; Peñas B; Zamora J
    Clin Liver Dis; 2010 May; 14(2):231-50. PubMed ID: 20682232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A rare case of gastric bleeding due to left-sided portal hypertension].
    Terrinoni V; Bianchi G; Lamazza A; Manili G; Bellini N; Carbone G; Rengo M
    G Chir; 1999 Apr; 20(4):185-7. PubMed ID: 10230124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.